drugset / Trial / NCT00549614

Effect of 4 Weeks Treatment With Acipimox in Patients With Chronic Heart Failure

NCT00549614

Completed 28 enrolled University of Aarhus
RandomizedCrossoverQuadruple-blindTreatment

Summary

The primary objective of this study is to evaluate whether metabolic modulation improves left ventricular function, work capacity, insulin sensitivity and modifies substrate metabolism in chronic heart failure

Timeline

Start
2007-10
Primary completion
2008-12
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Acipimox Small molecule 250 mg

Indications